Costanza Brunella, Umelo Ijeoma Adaku, Bellier Justine, Castronovo Vincent, Turtoi Andrei
Metastasis Research Laboratory, GIGA-Cancer, University of Liege, 4000 Liege, Belgium.
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université Montpellier, Institut Régional du Cancer de Montpellier, 34298 Montpellier, France.
J Clin Med. 2017 Jan 6;6(1):7. doi: 10.3390/jcm6010007.
Transforming growth factor-β (TGF-β) is an intriguing cytokine exhibiting dual activities in malignant disease. It is an important mediator of cancer invasion, metastasis and angiogenesis, on the one hand, while it exhibits anti-tumor functions on the other hand. Elucidating the precise role of TGF-β in malignant development and progression requires a better understanding of the molecular mechanisms involved in its tumor suppressor to tumor promoter switch. One important aspect of TGF-β function is its interaction with proteins within the tumor microenvironment. Several stromal proteins have the natural ability to interact and modulate TGF-β function. Understanding the complex interplay between the TGF-β signaling network and these stromal proteins may provide greater insight into the development of novel therapeutic strategies that target the TGF-β axis. The present review highlights our present understanding of how stroma modulates TGF-β activity in human cancers.
转化生长因子-β(TGF-β)是一种在恶性疾病中表现出双重活性的有趣细胞因子。一方面,它是癌症侵袭、转移和血管生成的重要介质,而另一方面,它又具有抗肿瘤功能。要阐明TGF-β在恶性肿瘤发生和发展中的精确作用,需要更好地理解其从肿瘤抑制因子向肿瘤促进因子转变所涉及的分子机制。TGF-β功能的一个重要方面是它与肿瘤微环境中的蛋白质相互作用。几种基质蛋白具有与TGF-β相互作用并调节其功能的天然能力。了解TGF-β信号网络与这些基质蛋白之间的复杂相互作用,可能会为开发靶向TGF-β轴的新型治疗策略提供更深入的见解。本综述重点介绍了我们目前对基质如何调节人类癌症中TGF-β活性的理解。